News
Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.
Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...
Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.
(Reuters) -Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...
Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...
20h
Pharmaceutical Technology on MSNEli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal
"Eli Lilly seeks more GPCR weight loss drugs in $1.3bn research deal" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...
Attorney General Ken Paxton filed a lawsuit this week against Eli Lilly for allegedly bribing Texas health care providers to ...
Texas has sued pharmaceutical giant Eli Lilly for allegedly bribing and illegally inducing medical providers to prescribe its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results